In this study, we demonstrated that curcumin and heptacosane are able to reverse P-gp transfer-mediated doxorubicin drug resistance and cause a phenotypic change in sensitive AML cells and heptacosane in breast cancer cell models. The gene discussed is PGP; the disease is breast carcinoma.